Xiaojing Cheng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 5
- S100 Proteins and Annexins 4
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 7
- Co-authors
- Jiafu Ji (38 shared papers)Hong Du (26 shared papers)Ting Guo (20 shared papers)Xiaofang Xing (21 shared papers)Xianzi Wen (16 shared papers)Lianhai Zhang (21 shared papers)Ziyu Li (14 shared papers)Ying Hu (15 shared papers)
- Journals
- Cancer Management and Research (4 papers)International Journal of Biological Sciences (3 papers)Scientific Reports (2 papers)Infection and Immunity (2 papers)Cancer Communications (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Xiaojing Cheng
56 papers receiving 1.2k citations
Xiaojing Cheng's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 312
- Oncology 352
- Molecular Biology 690
- Geriatrics and Gerontology 38
- Molecular Medicine 43
Countries citing papers authored by Xiaojing Cheng
This map shows the geographic impact of Xiaojing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Cheng more than expected).
Fields of papers citing papers by Xiaojing Cheng
This network shows the impact of papers produced by Xiaojing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Cheng. The network helps show where Xiaojing Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojing Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1‐Foxo1 and PI3K‐Akt signalling pathways Hit paper breakdown → | 2020 | 232 |
| 2 | 2014 | 103 | |
| 3 | 2020 | 55 | |
| 4 | 2017 | 54 | |
| 5 | 2014 | 52 | |
| 6 | 2014 | 47 | |
| 7 | 2015 | 44 | |
| 8 | 2012 | 42 | |
| 9 | 2019 | 40 | |
| 10 | 2022 | 40 | |
| 11 | 2019 | 37 | |
| 12 | 2007 | 32 | |
| 13 | 2020 | 32 | |
| 14 | 2012 | 29 | |
| 15 | 2021 | 28 | |
| 16 | 2016 | 24 | |
| 17 | 2013 | 23 | |
| 18 | 2019 | 22 | |
| 19 | 2018 | 19 | |
| 20 | 2021 | 18 |
About Xiaojing Cheng
Xiaojing Cheng is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (9 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers), Cancer Mechanisms and Therapy (5 papers), Ferroptosis and cancer prognosis (5 papers), Epigenetics and DNA Methylation (5 papers) and S100 Proteins and Annexins (4 papers). The work is most often cited by research in Cancer Research (312 citations), Oncology (352 citations), Molecular Biology (690 citations), Geriatrics and Gerontology (38 citations) and Molecular Medicine (43 citations). Xiaojing Cheng has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jiafu Ji, Hong Du, Ting Guo, Xiaofang Xing, Xianzi Wen, Lianhai Zhang, Ziyu Li, Ying Hu, Xiaohong Wang and Xiaoguang Cui. Their work appears in journals such as Cancer Management and Research, International Journal of Biological Sciences, Scientific Reports, Infection and Immunity and Cancer Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.